Allarity Therapeutics (ALLR) Q2 press release: R&D expenses fell to $1.3M and comprehensive loss narrowed to $3.7M vs 2025.
$ALLR
Price history, market instrument context, member research, and related headlines in one place.
ALLR key statistics
NasdaqCMUSD
52-week range
$0.76910%$1.84
Latest session $0.86–$0.8899Allarity Therapeutics, Inc. (ALLR) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $0.8733, up $0.00 (0.39%) from the previous close of $0.8699. It has traded between $0.86 and $0.8899 in the latest session. Over the past year it has ranged from $0.769 to $1.84, leaving it in the lower quarter of its 52-week range (10%). Reported volume for the session was 64K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Allarity Therapeutics reports Q2 results, cash position — See source for full details.
Loading $ALLR research…